DETECTION AND TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
DOI:
https://doi.org/10.11603/2415-8798.2018.3.9412Keywords:
familial hypercholesterolemia, hypolipidemic therapy, statinsAbstract
At present, the problem of the detection and treatment of patients with atherosclerosis is mainly due to the fact that there is no nationwide program to combat atherosclerosis, cholesterol screening and other risk factors, there is not enough adequate awareness of the population on the issues of this specialty and media support, ineffective vascular centers concerning reduction of lethality, insufficient patient adherence to the treatment, failure to reach the target levels of low density lipoprotein and inherent fear of administration the maximal doses of statins. Over the last decade, many data have been accumulated on familial hypercholesterolemia, and it is known that the prevalence of the disease has been more frequent than previously anticipated. Familial hypercholesterolemia is a hereditary disease that is associated with the early development of aggressive atherosclerosis and cardiovascular disease at young age, and is characterized by a severe course with high mortality. The paper provides an overview of the current state of epidemiology, prevention and management of patients with familial hypercholesterolemia, emphasizes the early detection of patients and screening of the family.
References
(2012). Semeynaya giperkholesterinemiya : obsledovaniye, diagnostika i lecheniye vzroslykh i detey. Klinicheskoye rukovodstvo gruppy ekspertov po semeynoy gi-perkholesterinemii Natsionalnoy lipidnoy assotsiatsii SSHA [Familial hypercholes-terolemia: examination, diagnosis and treatment of adults and children. Clinical Guide-lines of the Family Hypercholesterolemia Group of Experts at the United States National Lipid Association]. Afferentnaya i fiziko-khimicheskaya meditsina – Afferent and Physico-Chemical Medicine, 1, 3-9 [in Russian].
(2013). Sovremennyye rekomendatsii Yevropeyskogo obshchestva kardiologov i Yev-ropeyskogo obshchestva po bor'be s aterosklerozom po lecheniyu dislipidemiy [Modern recommendations of the European Society of Cardiology and the European Society for the fight against atherosclerosis for the treatment of dyslipidemia]. Ukrainskii terapevtichnyi zhurnal – Ukrainian Journal of Therapeutics, 2, 12-23 [in Russian].
Yezhov, M.V., Sergiyenko, I.V., & Ryzhkova, T.A. (2016). Rossiyskiye rekomendatsii po diagnostike i lecheniyu semeynoy giper-kholesterinemii [Russian recommendations on the diagnosis and treatment of familial hyper-cholesterolemia]. Ateroskleroz i dislipidemii – Atherosclerosis and Dyslipidemia, 4 (25), 21-29 [in Russian].
(2014). Integrated guidance on the care of familial hypercholesterolemia from the In-ternational FH Foundation. International Journal of Cardiology, 171, 309-325.
Nathan, D., Wong, D., Rosenblit, P., Greenfield, S.R. (2017). Advanced in dyslipidemia management for prevention of athero-sclerosis: PCSK9 monoclonal antibody therapy and beyond. Cardiovas. Diagn. Ther., 7 (Suppl. 1), 11-20.
Atheroscler, J. (2017). Half of century tales of familial hypercholesterolemia (FH) in Japan. Divi-sion of Clinical Lipidology, Department of Cardiology, Kanazawa University. Thromb, 24, 189-207.
Sharifi, M., Futema, M., Humphries, S.E. (2017). Genetic architecture of Familial Hy-percholesterolemia. Curr. Cardiol. Rep., 19, 19-44.
Hovingh, G.K., Davidson, M.H., Kastelein, J.J.P., & O’Connor, A.M. (2013). Diagnos-tic and treatment of familial hypercholesterolemia. Europen Heart J., 34, Issue 13, 962-971.
De Lorenzo, A., Duarte Lopes da Silva, J., James, C.E., Pereira, A.C., & Seixas Bello Moreira, A. (2018). Clinical, Anthropometric and biochemical characteristics of patients with or without genetically confirmed Familial Hypercholesterolemia. Arq. Bras. Cardiol, 110, 119-123.
Kłosiewicz-Latoszek, L., Cybulska, B., Białobrzeska-Paluszkiewicz, J., Jagielska, A., Janowska, J., Danowska, D., … & Stroniawska-Woźniak, M. (2018). Clinical manage-ment of heterozygous familial hypercholesterolemia in a Polish outpa-tient metabolic clinic : a retrospective observational study. Arch. Med. Sci., 14 (5), 962-970.
Downloads
Published
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
